查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2019065

體外診斷包裝市場機會、成長要素、產業趨勢分析及2026-2035年預測

In-Vitro Diagnostics Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 285 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球體外診斷包裝市場預計到 2025 年將達到 89 億美元，預計到 2035 年將以 5.5% 的複合年成長率成長至 149 億美元。

體外診斷包裝市場-IMG1

感染疾病上升、家用診斷解決方案的普及以及對無菌和防污染包裝日益嚴格的監管標準是成長要素。為維持生物檢體的穩定性，對低溫運輸包裝的需求不斷成長，也促進了市場發展。永續性正成為一大趨勢，製造商擴大採用可回收、生物基和單一材料包裝解決方案，以減少對環境的影響。自動化和高速包裝系統正在改變營運模式，提高效率並減少人為錯誤。同時，便攜性和人性化的設計正在推動醫療和研究領域分散式檢查和即時檢測技術的應用。

市場範圍
開始年份 2025
預測期 2026-2035
上市時的市場規模 89億美元
預測金額 149億美元
複合年成長率 5.5%

玻璃包裝市場預計將在2026年至2035年間以6.2%的複合年成長率成長，這主要得益於其化學惰性、熱穩定性和高純度等特性，使其成為儲存高靈敏度試劑和生物材料的理想選擇。玻璃管瓶、安瓿瓶和容器尤其適用於需要最大限度減少材料與內容物之間相互作用的特殊診斷應用，從而確保藥物和實驗室檢測的準確性。

預計到2025年，瓶裝和管瓶市場規模將達28億美元。這些包裝形式廣泛用於儲存診斷試劑、培養基和生物檢體。它們與滅菌流程、自動化分裝系統和低溫運輸要求相容，使其成為實驗室、醫院和集中檢測中心不可或缺的包裝形式。密封性佳、尺寸統一、耐化學腐蝕，確保符合法規要求，並獲得可靠的診斷結果。

至2025年，北美體外診斷包裝市佔率將達到35.1%。該地區的成長主要得益於嚴格的無菌、污染控制和低溫運輸管理法規。醫療和研究領域對快速就地檢驗的需求不斷成長，加速了先進包裝解決方案的普及。對擴充性、自動化和環保包裝系統的投資，以及智慧包裝（可實現溫度監控和供應鏈可追溯性）的整合，正在鞏固北美市場的領先地位。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章業界考察

  • 生態系分析
    • 供應商情況
    • 利潤率
    • 成本結構
    • 每個階段增加的價值
    • 影響價值鏈的因素
    • 中斷
  • 影響產業的因素
    • 促進因素
      • 全球感染疾病診斷檢測數量增加
      • 即時檢測套組的需求增加
      • 擴大對溫度敏感的體外診斷（IVD）產品的低溫運輸物流。
      • 無菌包裝有嚴格的監管要求
      • 居家診斷檢測的廣泛應用
    • 產業潛在風險與挑戰
      • 醫用塑膠供應鏈中斷
      • 無菌包裝的複雜驗證要求
    • 市場機遇
      • 永續和可回收醫療包裝的創新
      • 整合智慧包裝進行溫度監測
  • 成長潛力分析
  • 監理情勢
  • 波特五力分析
  • PESTEL 分析
  • 科技與創新趨勢
    • 當前技術趨勢
    • 新興技術
  • 價格趨勢
    • 按地區
    • 依產品
  • 定價策略
  • 新興經營模式
  • 合規要求
  • 專利和智慧財產權分析

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
    • 市場集中度分析
  • 主要企業的競爭標竿分析
    • 財務績效比較
      • 銷售量
      • 利潤率
      • 研究與發展（R&D）
    • 產品系列比較
      • 產品線寬度
      • 科技
      • 創新
    • 區域擴張比較
      • 全球擴張分析
      • 服務網路覆蓋
      • 按地區分類的市場滲透率
    • 競爭定位矩陣
      • 領導者
      • 挑戰者
      • 追蹤者
      • 小眾玩家
    • 戰略展望矩陣
  • 主要進展
    • 併購
    • 夥伴關係與合作
    • 技術進步
    • 業務拓展與投資策略
    • 數位轉型計劃
  • 新興/Start-Ups競爭對手的發展趨勢

第5章 市場估價與預測：依包裝產品類型分類，2022-2035年

  • 瓶子和管瓶
  • 試管和微型試管
  • 收納袋
  • 托盤泡殼
  • 測試盒和磁帶
  • 紙箱
  • 其他

第6章 市場估算與預測：依材料類型分類，2022-2035年

  • 塑膠
  • 玻璃
  • 紙張和紙板
  • 箔層壓

第7章 市場估算與預測：依體外診斷產品類型，2022-2035年

  • 試劑和檢測試劑盒
  • 檢體採集及運輸產品
  • 快速診斷檢測（RDT）
  • 分子診斷試劑盒
  • 其他

第8章 市場估算與預測：依最終使用者分類，2022-2035年

  • 體外診斷製造商
  • 合約包裝營運商 (CPO)
  • 醫療設備OEM製造商

第9章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第10章：公司簡介

  • 主要企業
    • Amcor Limited
    • Aptargroup Incorporated
    • Corning Incorporated
    • Greiner Holding AG
    • Oliver
    • VWR International, LLC.
  • 按地區分類的主要企業
    • 北美洲
      • Globe Scientific Inc.
      • Peacock Industries
      • FUSION BIOTECH
    • 亞太地區
      • Abdos Labtech Private Limited
      • ACADEMY MEDICAL INSTRUMENTS Limited Company
      • Amrit Scientific Ind. Private Limited
      • AdvaCare Pharma
      • Focus Technology Co., Ltd.
      • YuHuan KangJia
      • Zhuhai Ideal Biotech Co., Ltd
      • Ajosha Bio Teknik Pvt. Ltd.
    • 歐洲
      • Kindly（KDL）Group
      • Labtech Disposables
      • Narang Medical Limited
簡介目錄
Product Code: 12956

The Global In-Vitro Diagnostics Packaging Market was valued at USD 8.9 billion in 2025 and is estimated to grow at a CAGR of 5.5% to reach USD 14.9 billion in 2035.

In-Vitro Diagnostics Packaging Market - IMG1

Rising incidences of infectious diseases, growing home-based diagnostic solutions, and stricter regulatory standards for sterile and contamination-resistant packaging are key growth drivers. The market is also fueled by the rising need for cold chain-compatible packaging to maintain the stability of sensitive biological samples. Sustainability is emerging as a major trend, with manufacturers increasingly adopting recyclable, bio-based, and single-material packaging solutions to reduce environmental impact. Automation and high-speed packaging systems are reshaping operations, improving efficiency, and reducing human error, while portable and user-friendly designs support the growing adoption of decentralized and point-of-care testing across healthcare and research sectors.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$8.9 Billion
Forecast Value$14.9 Billion
CAGR5.5%

The glass packaging is expected to grow at a CAGR of 6.2% during 2026-2035, owing due to its chemical inertness, thermal stability, and high purity, making it ideal for sensitive reagents and biological materials. Glass vials, ampoules, and containers are preferred in specialized diagnostic applications requiring minimal interaction between the material and its contents, supporting precision in pharmaceutical and laboratory testing.

The bottles & vials segment reached USD 2.8 billion in 2025. These formats are widely used for storing diagnostic reagents, culture media, and biological samples. Their compatibility with sterilization processes, automated dispensing systems, and cold chain requirements makes them essential in laboratories, hospitals, and centralized testing centers. Secure sealing, consistent sizing, and high chemical resistance ensure regulatory compliance and reliable diagnostic outcomes.

North America In-Vitro Diagnostics Packaging Market held a 35.1% share in 2025. The region's growth is supported by strict regulations on sterility, contamination control, and cold chain management. Rising demand for rapid and point-of-care testing in healthcare and research sectors accelerates the adoption of advanced packaging solutions. Investments in scalable, automated, and eco-friendly packaging systems, along with smart packaging integration for temperature monitoring and supply chain traceability, reinforce North America's leadership in the market.

Leading players in the Global In-Vitro Diagnostics Packaging Market include Amcor Limited, Corning Incorporated, Aptargroup Incorporated, Greiner Holding AG, VWR International, LLC., Focus Technology Co., Ltd., YuHuan KangJia, Labtech Disposables, Peacock Industries, Oliver, Abdos Labtech Private Limited, AdvaCare Pharma, ACADEMY MEDICAL INSTRUMENTS Limited Company, Ajosha Bio Teknik Pvt. Ltd., Amrit Scientific Ind. Private Limited and Zhuhai Ideal Biotech Co., Ltd. Companies in the In-Vitro Diagnostics Packaging Market are focusing on several key strategies to strengthen their market position. They are investing in research and development to design sustainable, recyclable, and bio-based packaging materials that comply with evolving environmental regulations. Expansion of automated and high-speed packaging solutions improves production efficiency and reduces human error. Firms enhance product portfolios with portable, user-friendly formats for point-of-care and home diagnostics. Strategic partnerships with healthcare providers and diagnostic companies enable broader market reach. Adoption of smart packaging for cold chain monitoring and traceability strengthens reliability and customer trust. Companies also leverage digital marketing, supply chain integration, and global distribution networks to increase accessibility and maintain a competitive advantage in this rapidly growing market.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis, 2022 - 2035
  • 2.2 Key market trends
    • 2.2.1 Packaging product type trends
    • 2.2.2 Material type trends
    • 2.2.3 IVD product category trends
    • 2.2.4 End-user trends
    • 2.2.5 Regional trends
  • 2.3 TAM Analysis, 2026-2035
  • 2.4 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Cost structure
    • 3.1.4 Value addition at each stage
    • 3.1.5 Factor affecting the value chain
    • 3.1.6 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising infectious disease diagnostics volume globally
      • 3.2.1.2 Growth in point-of-care testing kits demand
      • 3.2.1.3 Cold chain logistics expansion for temperature-sensitive IVDs
      • 3.2.1.4 Stringent regulatory requirements for sterile packaging
      • 3.2.1.5 Increasing home-based diagnostic testing adoption
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Supply chain disruptions in medical-grade plastics
      • 3.2.2.2 Complex validation requirements for sterile packaging
    • 3.2.3 Market opportunities
      • 3.2.3.1 Sustainable and recyclable medical packaging innovations
      • 3.2.3.2 Smart packaging integration for temperature monitoring
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis
  • 3.7 Technology and Innovation landscape
    • 3.7.1 Current technological trends
    • 3.7.2 Emerging technologies
  • 3.8 Price trends
    • 3.8.1 By region
    • 3.8.2 By product
  • 3.9 Pricing Strategies
  • 3.10 Emerging Business Models
  • 3.11 Compliance Requirements
  • 3.12 Patent and IP analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East & Africa
    • 4.2.2 Market concentration analysis
  • 4.3 Competitive benchmarking of key players
    • 4.3.1 Financial performance comparison
      • 4.3.1.1 Revenue
      • 4.3.1.2 Profit margin
      • 4.3.1.3 R&D
    • 4.3.2 Product portfolio comparison
      • 4.3.2.1 Product range breadth
      • 4.3.2.2 Technology
      • 4.3.2.3 Innovation
    • 4.3.3 Geographic presence comparison
      • 4.3.3.1 Global footprint analysis
      • 4.3.3.2 Service network coverage
      • 4.3.3.3 Market penetration by region
    • 4.3.4 Competitive positioning matrix
      • 4.3.4.1 Leaders
      • 4.3.4.2 Challengers
      • 4.3.4.3 Followers
      • 4.3.4.4 Niche players
    • 4.3.5 Strategic outlook matrix
  • 4.4 Key developments
    • 4.4.1 Mergers and acquisitions
    • 4.4.2 Partnerships and collaborations
    • 4.4.3 Technological advancements
    • 4.4.4 Expansion and investment strategies
    • 4.4.5 Digital transformation initiatives
  • 4.5 Emerging/ startup competitors landscape

Chapter 5 Market Estimates and Forecast, By Packaging Product Type, 2022 - 2035 (USD Million)

  • 5.1 Key trends
  • 5.2 Bottles & vials
  • 5.3 Tubes & microtubes
  • 5.4 Pouches & bags
  • 5.5 Trays & blisters
  • 5.6 Test cartridges & cassettes
  • 5.7 Cartons & boxes
  • 5.8 Others

Chapter 6 Market Estimates and Forecast, By Material Type, 2022 - 2035 (USD Million)

  • 6.1 Key trends
  • 6.2 Plastics
  • 6.3 Glass
  • 6.4 Paper & paperboard
  • 6.5 Foil laminates

Chapter 7 Market Estimates and Forecast, By IVD Product Category, 2022 - 2035 (USD Million)

  • 7.1 Key trends
  • 7.2 Reagents & assay kits
  • 7.3 Sample collection & transport Products
  • 7.4 Rapid diagnostic tests (RDTs)
  • 7.5 Molecular diagnostic kits
  • 7.6 Others

Chapter 8 Market Estimates and Forecast, By End-User, 2022 - 2035 (USD Million)

  • 8.1 Key trends
  • 8.2 IVD manufacturers
  • 8.3 Contract packaging organizations (CPOs)
  • 8.4 Medical device OEMs

Chapter 9 Market Estimates and Forecast, By Region, 2022 - 2035 (USD Million)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Global Key Players
    • 10.1.1 Amcor Limited
    • 10.1.2 Aptargroup Incorporated
    • 10.1.3 Corning Incorporated
    • 10.1.4 Greiner Holding AG
    • 10.1.5 Oliver
    • 10.1.6 VWR International, LLC.
  • 10.2 Regional key players
    • 10.2.1 North America
      • 10.2.1.1 Globe Scientific Inc.
      • 10.2.1.2 Peacock Industries
      • 10.2.1.3 FUSION BIOTECH
    • 10.2.2 Asia Pacific
      • 10.2.2.1 Abdos Labtech Private Limited
      • 10.2.2.2 ACADEMY MEDICAL INSTRUMENTS Limited Company
      • 10.2.2.3 Amrit Scientific Ind. Private Limited
      • 10.2.2.4 AdvaCare Pharma
      • 10.2.2.5 Focus Technology Co., Ltd.
      • 10.2.2.6 YuHuan KangJia
      • 10.2.2.7 Zhuhai Ideal Biotech Co., Ltd
      • 10.2.2.8 Ajosha Bio Teknik Pvt. Ltd.
    • 10.2.3 Europe
      • 10.2.3.1 Kindly (KDL) Group
      • 10.2.3.2 Labtech Disposables
      • 10.2.3.3 Narang Medical Limited